<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">farmaec</journal-id><journal-title-group><journal-title xml:lang="en">FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology</journal-title><trans-title-group xml:lang="ru"><trans-title>ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2070-4909</issn><issn pub-type="epub">2070-4933</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17749/2070-4909.2015.8.2.011-015</article-id><article-id custom-type="elpub" pub-id-type="custom">farmaec-99</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальные статьи</subject></subj-group></article-categories><title-group><article-title>CLINICAL AND ECONOMIC ANALYSIS OF THE USE OF DIFFERENT TYPES OF SYSTEMS OF VENOUS ACCESS IN THE TREATMENT OF CHILDREN WITH CANCER</article-title><trans-title-group xml:lang="ru"><trans-title>Клинико-экономический анализ использования различных систем венозного доступа при лечении детей с онкологическими заболеваниями</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рыков</surname><given-names>Максим Юрьевич</given-names></name><name name-style="western" xml:lang="en"><surname>Rykov</surname><given-names>Maksim Yur'evich</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., научный сотрудник отделения опухолей опорно-двигательного аппарата,</p><p>Каширское ш., д. 24, Москва 115478</p></bio><bio xml:lang="en"><p>PhD, researcher at the Department of tumors of the musculoskeletal system,</p><p>Kashirskoe sh., D. 24, Moscow, Russia, 115478</p></bio><email xlink:type="simple">wordex2006@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Поляков</surname><given-names>Владимир Георгиевич</given-names></name><name name-style="western" xml:lang="en"><surname>Polyakov</surname><given-names>Vladimir Georgievich</given-names></name></name-alternatives><bio xml:lang="ru"><p>академик РАН, д.м.н., проф., заместитель директора,</p><p>Каширское ш., д. 24, Москва, Россия, 115478</p></bio><bio xml:lang="en"><p>PhD, academician of RAS, prof., deputy director of the Institute,</p><p>Kashirskoe sh., D. 24, Moscow, Russia, 115478</p></bio><email xlink:type="simple">wordex2006@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">НИИ ДОГ ФГБНУ «РОНЦ им. Н.Н. Блохина»<country>Россия</country></aff><aff xml:lang="en">Institute of Pediatric Oncology and Hematology N.N. Blokhin<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>24</day><month>09</month><year>2015</year></pub-date><volume>8</volume><issue>2</issue><fpage>11</fpage><lpage>15</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Rykov M.Y., Polyakov V.G., 2015</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="ru">Рыков М.Ю., Поляков В.Г.</copyright-holder><copyright-holder xml:lang="en">Rykov M.Y., Polyakov V.G.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmacoeconomics.ru/jour/article/view/99">https://www.pharmacoeconomics.ru/jour/article/view/99</self-uri><abstract><sec><title>Introduction</title><p>Introduction. In the article the clinical and economic analysis of the use of different systems of venous access in the treatment of children with cancer.</p></sec><sec><title>Objective</title><p>Objective: to conduct clinical and economic analysis systems venous access in order to optimize the cost of treatment of children with cancer.</p></sec><sec><title>Materials and Methods</title><p>Materials and Methods. The experience of installing and operating the subclavian catheters and implantable venous port systems installed in 2262 for children between the ages of 2 months up to 17 years. To calculate the cost price were taken «Price list of paid medical services» and Rates of the compulsory health insurance.</p></sec><sec><title>Results</title><p>Results. As the number of annual primary identified children with cancer is on average 3.000 people, according to the price list prices temporarily, for the installation of each of them for a period of treatment five subclavian catheters necessary to spend 227.25 mln. rubles. And the implantations of venous ports – 156.00 mln. rubles. Thus, the savings of using implantable venous port-systems – 71.25 mln. rubles.</p></sec><sec><title>Conclusion</title><p>Conclusion. Mass introduction of the implantable venous ports will significantly reduce the cost of budgetary funds for the treatment of children with cancer, while lowering the percentage of complications and improve quality of life.</p></sec></abstract><trans-abstract xml:lang="ru"><p>В статье проведен клинико-экономический анализ использования различных систем венозного доступа при лечении детей с онкологическими заболеваниями.</p><p>Цель работы – провести клинико-экономический анализ систем венозного доступа с целью оптимизации расходов на лечение детей с онкологическими заболеваниями.</p><sec><title>Материалы и методы</title><p>Материалы и методы. Проанализирован опыт установки и эксплуатации подключичных катетеров и имплантируемых венозных порт-систем у 2262 детей в возрасте от 2 мес. до 17 лет. Для расчетов затрат были взяты цены «Временного прейскуранта платных медицинских услуг» РОНЦ им. Н.Н. Блохина и тарифы ОМС.</p></sec><sec><title>Результаты</title><p>Результаты. Поскольку количество ежегодно выявляемых первичных детей с онкологическими заболеваниями составляет в среднем 3000 человек, согласно ценам временного прейскуранта на установку каждому из них за период лечения пяти внешних центральных венозных катетеров необходимо затратить 227250000 руб., а на имплантацию порт-систем – 156000000 руб. Таким образом, экономия при использовании имплантируемых венозных порт-систем составляет 71250000 руб.</p></sec><sec><title>Заключение</title><p>Заключение. Массовое внедрение имплантируемых венозных порт-систем позволит существенно сократить расходы бюджетных средств на лечение детей с онкологическими заболеваниями, одновременно снизив процент осложнений и повысив качество жизни.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>Детская онкология</kwd><kwd>венозный доступ</kwd><kwd>качество медицинских услуг</kwd><kwd>клинико-экономический анализ</kwd><kwd>подключичные катетеры</kwd><kwd>имплантируемые венозные порт-системы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Pediatric oncology</kwd><kwd>venous access</kwd><kwd>quality of health services</kwd><kwd>clinical and economic analysis</kwd><kwd>subclavian catheters</kwd><kwd>implantable venous portsystems</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Abstracts from WoCoVA 2010, 1st World Congress on Vascular Access. Amsterdam. June 16-18. J. Vasc. Access. 2011; 12 (1): 79-98.</mixed-citation><mixed-citation xml:lang="en">Abstracts from WoCoVA 2010, 1st World Congress on Vascular Access. Amsterdam. June 16-18. J. Vasc. Access. 2011; 12 (1): 79-98.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Abstracts from WoCoVA 2012, 2nd World Congress on Vascular Access. Amsterdam. June 27-29. J. Vasc. Access. 2012; 13 (2): 1-40.</mixed-citation><mixed-citation xml:lang="en">Abstracts from WoCoVA 2012, 2nd World Congress on Vascular Access. Amsterdam. June 27-29. J. Vasc. Access. 2012; 13 (2): 1-40.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Abstracts from VAS 8th International Congress. April 25-27. Prague. J. Vasc. Access. 2013; 14 (1): 1-68.</mixed-citation><mixed-citation xml:lang="en">Abstracts from VAS 8th International Congress. April 25-27. Prague. J. Vasc. Access. 2013; 14 (1): 1-68.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Abstracts from WoCoVA 2014, 3rd World Congress on Vascular Access, Berlin. June 18-20. J. Vasc. Access. 2014; 15 (3): 193-239.</mixed-citation><mixed-citation xml:lang="en">Abstracts from WoCoVA 2014, 3rd World Congress on Vascular Access, Berlin. June 18-20. J. Vasc. Access. 2014; 15 (3): 193-239.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Abstracts from VAS 9th International Congress, April 15-18. Barcelona. J. Vasc. Access. 2015; 16 (2): e13-e36.</mixed-citation><mixed-citation xml:lang="en">Abstracts from VAS 9th International Congress, April 15-18. Barcelona. J. Vasc. Access. 2015; 16 (2): e13-e36.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Craus W., Di Giacomo A., Tommasino U., Frezza A., Festa G., Cricr A. Totally Implantable Central Venous Access: 15 years experience in a single unit. J. Vasc. Access. 2001; 2 (4): 161-167.</mixed-citation><mixed-citation xml:lang="en">Craus W., Di Giacomo A., Tommasino U., Frezza A., Festa G., Cricr A. Totally Implantable Central Venous Access: 15 years experience in a single unit. J. Vasc. Access. 2001; 2 (4): 161-167.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Crocoli A., Tornesello A., Pittiruti M., Barone A., Muggeo P., Inserra A., Molinary A., Grillenzoni V. Central venous access devices in pediatric malignancies: a position paper of Italian Association of Pediatric Hematology and Oncology. J. Vasc. Access. 2015; 16 (2): 130-136.</mixed-citation><mixed-citation xml:lang="en">Crocoli A., Tornesello A., Pittiruti M., Barone A., Muggeo P., Inserra A., Molinary A., Grillenzoni V. Central venous access devices in pediatric malignancies: a position paper of Italian Association of Pediatric Hematology and Oncology. J. Vasc. Access. 2015; 16 (2): 130-136.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Haag G., Berger A., Jager D. Treatment of long-term catheterrelated bloodstream infections with a taurolidine block: a single cancer center experience. J. Vasc. Access. 2011; 12 (3): 244-247.</mixed-citation><mixed-citation xml:lang="en">Haag G., Berger A., Jager D. Treatment of long-term catheterrelated bloodstream infections with a taurolidine block: a single cancer center experience. J. Vasc. Access. 2011; 12 (3): 244-247.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Hameeteman M., Bode A., Peppelenbosch A., Van der Sande F., Tordoir J. Ultrasoun-guided central venous catheter placement by surgical trainees: A safe procedure? J. Vasc. Access. 2010; 11 (4): 288-292.</mixed-citation><mixed-citation xml:lang="en">Hameeteman M., Bode A., Peppelenbosch A., Van der Sande F., Tordoir J. Ultrasoun-guided central venous catheter placement by surgical trainees: A safe procedure? J. Vasc. Access. 2010; 11 (4): 288-292.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kurul S., Saip P., Aydin T. Totally implantable venous-access ports: local problems and extravasation injury. The Lancet Oncology. 2002; 3 (11): 684-692.</mixed-citation><mixed-citation xml:lang="en">Kurul S., Saip P., Aydin T. Totally implantable venous-access ports: local problems and extravasation injury. The Lancet Oncology. 2002; 3 (11): 684-692.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Perin G., Scarpa M. Defining central venoua line position in children: tips for the tip. J. Vasc. Access. 2015; 16 (2): 77-86.</mixed-citation><mixed-citation xml:lang="en">Perin G., Scarpa M. Defining central venoua line position in children: tips for the tip. J. Vasc. Access. 2015; 16 (2): 77-86.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Perdikakis E., Kehagias E., Tsetis D. Common and uncommon complications of totally implantable central venous ports. J. Vasc. Access. 2012; 13 (3): 345-350.</mixed-citation><mixed-citation xml:lang="en">Perdikakis E., Kehagias E., Tsetis D. Common and uncommon complications of totally implantable central venous ports. J. Vasc. Access. 2012; 13 (3): 345-350.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Pittiruti M., Emoli A., Cappuccio S., LaGreca A. A new wireless device for tip location using the intracavitary ECG technique. J. Vasc. Access. 2014; 15 (3): 206.</mixed-citation><mixed-citation xml:lang="en">Pittiruti M., Emoli A., Cappuccio S., LaGreca A. A new wireless device for tip location using the intracavitary ECG technique. J. Vasc. Access. 2014; 15 (3): 206.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Tordoir J., Canaud B., Haage P., Konner K. et al. EBPG on Vascular Access Nephrol. Dial Transplant. 2007; 22 (2) ii88-ii117.</mixed-citation><mixed-citation xml:lang="en">Tordoir J., Canaud B., Haage P., Konner K. et al. EBPG on Vascular Access Nephrol. Dial Transplant. 2007; 22 (2) ii88-ii117.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Wilson S. Vascular Access: Principles and Practice. Edition 5. Philadelphia. 2010; 317 p.</mixed-citation><mixed-citation xml:lang="en">Wilson S. Vascular Access: Principles and Practice. Edition 5. Philadelphia. 2010; 317 p.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
